Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lacy

Showing results (541-550 of 553) with videos related to

Pageof 56
Sort By:
Journal for Immunotherapy of Cancer|June 11, 2021
Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2Giulia Pellizzari, Olivier Martinez, Silvia Crescioli, et al.
Gastroenterology|April 30, 2015
Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled StudyNicholas J Talley, G Richard Locke, Yuri A Saito, et al.
Scientific Reports|July 15, 2016
IgG subclass switching and clonal expansion in cutaneous melanoma and normal skinLouise Saul, Kristina M Ilieva, Heather J Bax, et al.
The American Journal of Gastroenterology|March 15, 2017
Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment TrialYuri A Saito, G Richard Locke, Ann E Almazar, et al.
The Journal of Clinical Investigation|March 5, 2013
IgG4 subclass antibodies impair antitumor immunity in melanomaPanagiotis Karagiannis, Amy E Gilbert, Debra H Josephs, et al.
Frontiers in Immunology|February 11, 2021
B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor AntibodiesZena N Willsmore, Robert J Harris, Silvia Crescioli, et al.
European Journal of Immunology|January 15, 2021
Combined anti-PD-1 and anti-CTLA-4 checkpoint blockade: Treatment of melanoma and immune mechanisms of actionZena N Willsmore, Ben G T Coumbe, Silvia Crescioli, et al.
Frontiers in Immunology|April 4, 2019
Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in MelanomaDuaa O Khair, Heather J Bax, Silvia Mele, et al.
Histopathology|July 22, 2014
Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET)Aaron M Gruver, Ling Liu, Peter Vaillancourt, et al.
Cancer Research|July 5, 2021
Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast CancerRobert J Harris, Anthony Cheung, Joseph C F Ng, et al.
Pageof 56

Showing results (541-550 of 553) with videos related to

Sort By:
Pageof 56
Journal for Immunotherapy of Cancer|June 11, 2021
Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2Giulia Pellizzari, Olivier Martinez, Silvia Crescioli, et al.
Gastroenterology|April 30, 2015
Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled StudyNicholas J Talley, G Richard Locke, Yuri A Saito, et al.
Scientific Reports|July 15, 2016
IgG subclass switching and clonal expansion in cutaneous melanoma and normal skinLouise Saul, Kristina M Ilieva, Heather J Bax, et al.
The American Journal of Gastroenterology|March 15, 2017
Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment TrialYuri A Saito, G Richard Locke, Ann E Almazar, et al.
The Journal of Clinical Investigation|March 5, 2013
IgG4 subclass antibodies impair antitumor immunity in melanomaPanagiotis Karagiannis, Amy E Gilbert, Debra H Josephs, et al.
Frontiers in Immunology|February 11, 2021
B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor AntibodiesZena N Willsmore, Robert J Harris, Silvia Crescioli, et al.
European Journal of Immunology|January 15, 2021
Combined anti-PD-1 and anti-CTLA-4 checkpoint blockade: Treatment of melanoma and immune mechanisms of actionZena N Willsmore, Ben G T Coumbe, Silvia Crescioli, et al.
Frontiers in Immunology|April 4, 2019
Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in MelanomaDuaa O Khair, Heather J Bax, Silvia Mele, et al.
Histopathology|July 22, 2014
Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET)Aaron M Gruver, Ling Liu, Peter Vaillancourt, et al.
Cancer Research|July 5, 2021
Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast CancerRobert J Harris, Anthony Cheung, Joseph C F Ng, et al.
Pageof 56